Table 3.
Cytokine | Method | PSP/CBS | MSA | PD | Controls | p-value |
---|---|---|---|---|---|---|
ICAM-1 |
Array |
0.98 ± 0.25 |
0.47 ± 0.09 |
0.62 ± 0.15 |
1.00 ± 0.28 |
<0.05a |
(ICAM1) |
FCM |
1.25 ± 0.85 |
0.75 ± 0.29 |
0.86 ± 0.43 |
1.00 ± 0.73 |
nsb |
IL-2 Ra |
Array |
2.14 ± 0.47 |
1.87 ± 0.10 |
1.24 ± 0.06 |
1.00 ± 0.14 |
<0.05a |
(IL2RA) |
ELISA |
1.44 ± 0.76 |
1.24 ± 0.61 |
1.15 ± 0.55 |
1.00 ± 0.29 |
nsb |
Leptin |
Array |
1.93 ± 0.11 |
1.13 ± 0.23 |
1.91 ± 0.46 |
1.00 ± 0.11 |
<0.05a |
(LEP) |
FCM |
2.95 ± 4.89 |
1.42 ± 1.15 |
1.86 ± 1.88 |
1.00 ± 0.89 |
nsb |
MCP-4 |
Array |
7.18 ± 0.85 |
2.16 ± 1.39 |
1.71 ± 0.80 |
1.00 ± 0.76 |
<0.05a |
(CCL13) |
ELISA |
1.15 ± 0.32 |
0.91 ± 0.37 |
1.02 ± 0.32 |
1.00 ± 0.42 |
nsb |
PDGF-BB |
Array |
1.87 ± 0.50 |
1.34 ± 0.18 |
1.34 ± 0.22 |
1.00 ± 0.44 |
<0.05a |
(PDGFB) |
FCM |
1.42 ± 0.30 |
1.32 ± 0.39 |
1.11 ± 0.28 |
1.00 ± 0.33 |
<0.05b |
Prolactin |
Array |
4.17 ± 1.74 |
1.03 ± 0.15 |
0.99 ± 0.08 |
1.00 ± 0.19 |
<0.05a |
(PRL) |
ELISA |
3.06 ± 4.15 |
1.39 ± 1.34 |
0.71 ± 1.12 |
1.00 ± 0.50 |
<0.05b |
RANTES |
Array |
1.46 ± 0.29 |
1.32 ± 0.11 |
1.20 ± 0.25 |
1.00 ± 0.20 |
<0.05a |
(CCL5) | ELISA | 1.13 ± 0.59 | 0.83 ±0.49 | 0.94 ± 0.32 | 1.00 ± 0.51 | nsb |
Cytokine microarray data were validated by ELISA (MCP-4, prolactin, RANTES and IL-2RA) or by Flow-Cytomix assays (ICAM-1, Leptin and PDGF-BB) in individual samples. All data are shown as means with standard deviations of the ratio to the mean of the control group. Array = Raybiotech cytokine microarray, FCM = Flow-Cytomix, ELISA = enzyme-linked immunosorbent assay, ns = statistically non significant.
P-value: groups were compared using a SAM analysis and b Kruskal-Wallis test.